RT Journal Article
SR Electronic
T1 Deducing the Dose-response Relation for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.26.20140624
DO 10.1101/2020.06.26.20140624
A1 Zhang, Xiaole
A1 Wang, Jing
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.06.26.20140624.abstract
AB The fundamental dose-response relation is still missing for better evaluating and controlling the transmission risk of COVID-19. A recent study by Chu et al. has indicated that the anticipated probability of viral infection is about 12.8% within 1 m and about 2.6% at further distance through a systematic review and meta-analysis. This important information provides us a unique opportunity to assess the dose-response relation of the viruses, if reasonable exposure dose could be estimated. Here we developed a simple framework to integrate the a priori dose-response relation for SARS-CoV based on mice experiments, and the recent data on infection risk and viral shedding, to shed light on the dose-response relation for human. The developed dose-response relation is an exponential function with a constant k in the range of 6.19×104 to 7.28×105 virus copies. The result mean that the infection risk caused by one virus copy in viral shedding is about 1.5×10−6 to 1.6×10−5. The developed dose-response relation provides a tool to quantify the magnitude of the infection risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for the present work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was needed for the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data referred to in the manuscript are from published literature.